Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants

PURPOSE: Pregnant women have unprecedented choices for prenatal screening and testing. Cell-free DNA (cfDNA) offers the option to screen for aneuploidy of all chromosomes and genome-wide copy-number variants (CNVs), expanding screening beyond the common trisomies (“traditional” cfDNA). We sought to...

Descripción completa

Detalles Bibliográficos
Autores principales: Soster, Erica, Boomer, Theresa, Hicks, Susan, Caldwell, Samantha, Dyr, Brittany, Chibuk, Jason, Almasri, Eyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257487/
https://www.ncbi.nlm.nih.gov/pubmed/33731879
http://dx.doi.org/10.1038/s41436-021-01135-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257487/
https://www.ncbi.nlm.nih.gov/pubmed/33731879
http://dx.doi.org/10.1038/s41436-021-01135-8

Ejemplares similares